LRP16 Promotes Invasive Growth of MCF-7 Cells by Regulation of E-cadherin Expression

HAN Wei-Dong,MENG Yuan-Guang,LIAO Dai-Xiang,LI Qi,WU Zhi-Qiang,SI Yi-Ling,HAO Hao-Jie,MU Yi-Ming,ZHAO Ya-Li

DOI: https://doi.org/10.3969/j.issn.1007-7626.2006.09.007

2006-01-01

Abstract:The clinopathyological data indicated that the expression level of LRP16 was positively correlated with the status of estrogen-receptor α(ERα) and involvement of axillary lymphoid nodes in primary breast cancer samples. Here, the effect of LRP16 on the invasive growth ability of human breast cancer MCF-7 cells and the involved molecular mechanism was investigated. The cellular adhesion, invasion and migration abilities were firstly measured by metrical gel adhesion assay and modified Boyden chamber (Transwell assays) and the results showed that suppression of LRP16 markedly reduced the adhesion, invasive and migration abilities of MCF-7 cells. The results of in vivo metastatic experiments demonstrated that suppression of the endogenous LRP16 significantly reduced the lung metastasis formation of MCF-7 cells. To further screen the expression changes of metastasis associated molecules in LRP16-suppressed MCF-7 cells, the protein levels of MMP-2, MMP-9, CD44 and E-cadherin were analyzed by Western blotting. The results demonstrated that only E-cadherin was up-regulated in LRP16-inhibitory MCF-7 cells. Further results from Northern blot and immunohistochemistry analyses comfirmed that inhibition of LRP16 caused the increases of E-cadherin both at mRNA and protein levels. To further determine the possible regulation effects of LRP16 on E-cadherin transactivation, the luciferase reporter driven by 5'-proximal regulatory region of E-cadherin gene was used to cotransfect with different dose LRP16 expression vector. Results analysis from luciferase assays indicated that the transactivation of E-cadherin promoter (-105 bp to +125 bp) was suppressed by LRP16 in a dose-dependent manner in ERα-positive MCF-7 and HT29 cells in the presence of E2, but not in ER α-negative MDA-MB-231 and Caco-2 cells. Finally, the interaction of ERα and E-cadherin regulatory region was investigated by chromatin immunoprecipitation (ChIP) assays and the results suggested that the inhibition of LRP16 gene in MCF-7 cells enhanced the interaction between ERα and the DNA fragment of E-cadherin regulatory region. Taken together, these data demonstrated that inhibition of LRP16 expression attenuated the invasive growth of ERα-positive breast cancer cells, the molecular mechanism of which involved the transcriptional activity of E-cadherin through inhibition of LRP16 via ERα mediation.